Aaron Smith, DO
Urology · Iowa City, IANPI 1871614149
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $831 of the $1,233 with a category attached, or 67.4%. Axonics, Inc. accounts for 79.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $977 and has fallen 96.1% since, to $38 in 2024. That places this record below the midpoint for urology clinicians in IA, where the typical reported total is $1,504.
Across 22 payments — averaging $56.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$977
- Dornier Medtech America, Inc$67
- Pfizer$65
- Intuitive Surgical$38
- Teleflex LLC$26
- AbbVie$25
- plus $37 from 2 others
What the payments were for
- Travel & lodging$83167%
- Food & beverage$38531%
- Education$171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 10 | $977 |
| Dornier Medtech America, Inc | 1 | $67 |
| Pfizer | 5 | $65 |
| Intuitive Surgical | 1 | $38 |
| Teleflex LLC | 1 | $26 |
| AbbVie(2 entities) | 2 | $25 |
| Bayer | 1 | $20 |
| Coloplast | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,233 in reported general payments places this provider in the 40th percentile of 114 urology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 143 | $69,984 |
| Trospium Chloride | 85 | $3,626 |
| Potassium Citrate ErPotassium Citrate | 56 | $3,310 |
| Tamsulosin Hcl | 281 | $2,777 |
| Silodosin | 72 | $2,304 |
| Methenamine Hippurate | 40 | $1,939 |
| Dutasteride | 91 | $1,593 |
| Trimethoprim | 20 | $1,144 |
| Finasteride | 133 | $1,100 |
| Estradiol | 15 | $853 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 51 | $808 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 48 | $587 |
| Gentamicin Sulfate | 29 | $563 |
| Cephalexin | 156 | $559 |
| Bethanechol Chloride | 20 | $494 |
Paid to pharmacies, not to this prescriber.
Other urology in Iowa City
- Vignesh PackiamIowa City$112K
- Annah VollstedtIowa City$66K
- Bradley EricksonIowa City$65K
- Michael OdonnellIowa City$62K
- Alexandria HertzIowa City$53K
- John BuieIowa City$52K
- Charles SchlaepferIowa City$51K
- Christopher CooperIowa City$10K
- Amanda MyersIowa City$7K
- Luke BrunkhorstIowa City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.